LC
EXAS

Lindbrook Capital’s Exact Sciences EXAS Stock Holding History

Lindbrook Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$11.1K Sell
256
-251
-50% -$12.7K ﹤0.01% 1604
2024
Q4 		$28.5K Buy
507
+10
+2% +$622 ﹤0.01% 1092
2024
Q3 		$33.9K Buy
497
+343
+223% +$19.4K ﹤0.01% 1008
2024
Q2 		$6.51K Sell
154
-268
-64% -$14.7K ﹤0.01% 1868
2024
Q1 		$29.1K Buy
422
+143
+51% +$9.04K ﹤0.01% 1022
2023
Q4 		$20.6K Buy
279
+151
+118% +$9.9K ﹤0.01% 1159
2023
Q3 		$8.73K Sell
128
-44
-26% -$3.73K ﹤0.01% 1485
2023
Q2 		$16.2K Buy
172
+55
+47% +$4.29K ﹤0.01% 1203
2023
Q1 		$7.93K Hold
117
– – ﹤0.01% 1600
2022
Q4 		$5.79K Buy
117
+18
+18% +$735 ﹤0.01% 1737
2022
Q3 		$3K Buy
99
+63
+175% +$2.6K ﹤0.01% 1864
2022
Q2 		$1K Sell
36
-18
-33% -$963 ﹤0.01% 2221
2022
Q1 		$4K Sell
54
-1
-2% -$73 ﹤0.01% 1689
2021
Q4 		$4K Sell
55
-5
-8% -$441 ﹤0.01% 1571
2021
Q3 		$6K Buy
60
+4
+7% +$422 ﹤0.01% 1182
2021
Q2 		$7K Buy
56
+12
+27% +$1.43K ﹤0.01% 1184
2021
Q1 		$6K Buy
44
+10
+29% +$1.37K ﹤0.01% 1203
2020
Q4 		$5K Buy
34
+4
+13% +$484 ﹤0.01% 1178
2020
Q3 		$3K Sell
30
-15
-33% -$1.29K ﹤0.01% 1259
2020
Q2 		$4K Hold
45
– – ﹤0.01% 1151
2020
Q1 		$3K Buy
45
+11
+32% +$893 ﹤0.01% 1182
2019
Q4 		$3K Hold
34
– – ﹤0.01% 1199
2019
Q3 		$3K Sell
34
-6
-15% -$684 ﹤0.01% 1171
2019
Q2 		$4K Hold
40
– – ﹤0.01% 1095
2019
Q1 		$3K Hold
40
– – ﹤0.01% 1161
2018
Q4 		$2K Buy
+40
New +$2.75K ﹤0.01% 1167

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's EXAS Position: Q1 2025 in Review

Lindbrook Capital reduced its Exact Sciences (EXAS) stake by 50% in Q1 2025, selling an estimated $12.7K and leaving 256 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Lindbrook Capital first reported a position in EXAS in Q4 2018 and has held it in 26 quarters since. The position peaked at $33.9K in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Lindbrook Capital held 256 shares of Exact Sciences worth $11.1K as of Q1 2025.
  • Lindbrook Capital sold 251 Exact Sciences shares in Q1 2025, an estimated $12.7K.
  • Exact Sciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1604 holding.
  • Lindbrook Capital first reported a position in Exact Sciences in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Exact Sciences position peaked at $33.9K in Q3 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.